以氨酸为基础的微型和纳米技术向炎症:以疾病为导向的综述
Fatemeh Senobari1, Samira Sadat Abolmaali2, Ghazal Farahavr1
1Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz 71345, Iran.
International journal of biological macromolecules
|September 25, 2024
概括
氨酸 (HA) 为炎症提供先进的药物输送,改善生物可用性和减少副作用. 基于HA的系统有望有效治疗各种炎症性疾病.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 药物输送系统 药物输送系统
背景情况:
- 炎症是许多疾病的关键免疫反应,由于药物限制,如生物可用性差和副作用,造成治疗挑战.
- 传统的抗炎药物和细胞因子抑制剂在有效性和安全性方面遇到障碍.
- 氨酸 (HA) 是一种生物聚合物,因其在药物输送中的治疗潜力而得到认可.
研究的目的:
- 审查基于氨酸 (HA) 的药物输送系统在管理炎症状况方面的最新进展.
- 探索HA药理学,材料设计和用于炎症治疗的制造技术.
- 突出HA在各种炎症性疾病中的应用及其临床翻译潜力.
主要方法:
- 对氨酸 (HA) 药理学及其在免疫调节中的作用的当前文献的综述.
- 分析微型和纳米技术用于制造HA工程药物输送系统 (水凝,纳米凝等). ) 的情况.
- 在各种炎症性疾病中检查基于HA的系统应用程序.
主要成果:
- 氨酸 (HA) 具有独特的特性 (水友性,生物降解性,安全性),适用于药物输送.
- 基于HA的系统利用被动和主动向来增强抗炎药物输送,减少所需剂量和不良影响.
- 制造方法包括水凝,纳米凝,微针,纳米纤维和3D支架,用于各种管理路径.
结论:
- 基于氨酸 (HA) 的药物输送系统为有效的炎症管理提供了双重策略.
- 这些系统通过提高药物的生物可用性和最大限度地减少目标外影响来改善治疗结果.
- 在治疗各种炎症性疾病方面,HA具有显著的临床转化潜力.
相关概念视频
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
Inflammation
53.2K
Overview
53.2K


